ATE221324T1 - Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms - Google Patents

Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms

Info

Publication number
ATE221324T1
ATE221324T1 AT96203249T AT96203249T ATE221324T1 AT E221324 T1 ATE221324 T1 AT E221324T1 AT 96203249 T AT96203249 T AT 96203249T AT 96203249 T AT96203249 T AT 96203249T AT E221324 T1 ATE221324 T1 AT E221324T1
Authority
AT
Austria
Prior art keywords
acid
fatty acids
nutritional composition
metabolic syndrome
fat
Prior art date
Application number
AT96203249T
Other languages
English (en)
Inventor
Hans-Ulrich Bernhard Kloer
Annette Hauenschild
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of ATE221324T1 publication Critical patent/ATE221324T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96203249T 1996-11-20 1996-11-20 Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms ATE221324T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96203249A EP0843972B1 (de) 1996-11-20 1996-11-20 Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselssyndroms

Publications (1)

Publication Number Publication Date
ATE221324T1 true ATE221324T1 (de) 2002-08-15

Family

ID=8224602

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96203249T ATE221324T1 (de) 1996-11-20 1996-11-20 Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms

Country Status (8)

Country Link
US (1) US5886037A (de)
EP (1) EP0843972B1 (de)
AT (1) ATE221324T1 (de)
DE (1) DE69622722T2 (de)
DK (1) DK0843972T3 (de)
ES (1) ES2179156T3 (de)
NO (1) NO320263B1 (de)
PT (1) PT843972E (de)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69817745T2 (de) * 1997-12-15 2004-07-01 Loders Croklaan B.V. Nicht-temperierte laurinarme Fettzusammensetzungen
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
DE19936831A1 (de) * 1999-08-05 2001-02-08 Basf Ag Verringerung von Cholesterinoxiden durch n-3-PUFA und Vitamin E
US6340705B1 (en) 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
US20070072927A1 (en) * 1999-09-23 2007-03-29 Vita Joseph A Nutritional supplement for increased energy and stamina
EP1062873A1 (de) * 1999-12-13 2000-12-27 N.V. Nutricia Verbessertes Säuglingsnährpräparat, Eiweisshydrolysat zur Verwendung in solchem Säuglingsnährpräparat, und Verfahren zur Herstellung solches Hydrolysates
AUPQ673300A0 (en) * 2000-04-06 2000-05-04 Penford Australia Limited Starch sub-types and lipid metabolism
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
US6927239B1 (en) * 2000-08-02 2005-08-09 Pharmanutrients Methods and compositions for the attenuation and/or prevention of stress/catabolic responses
WO2002009691A1 (en) * 2000-08-02 2002-02-07 Pharmanutrients Methods and compositions for the prevention and treatment of syndrome x
US6838451B1 (en) 2000-08-02 2005-01-04 Pharmanutrients Methods and compositions for the prevention and treatment of inflammation, osteoarthritis, and other degenerative joint diseases
US6667064B2 (en) * 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
WO2002043659A2 (en) * 2000-11-29 2002-06-06 Smithkline Beecham Corporation Composition containing statins and calcium for improved cardiovascular health
JP2004527501A (ja) * 2001-03-05 2004-09-09 ピー． アーネスト，スティーヴン 経腸処方
WO2003033633A1 (en) * 2001-10-18 2003-04-24 Council Of Scientific And Industrial Research Cholesterol lowering structured lipids with omega 3 pufa
US20040018248A1 (en) * 2001-11-29 2004-01-29 Adrianne Bendich Composition containing statins and calcium for improved cardiovascular health
US20030166614A1 (en) * 2002-03-01 2003-09-04 Harrison Stanley F. Method for reducing cholesterol and triglycerides
DE10214005A1 (de) * 2002-03-27 2003-10-09 Volker Bartz Blutfettsenker zur oralen Einnahme, bestehend aus einem Gemisch aus den Omega-3-Fettsäuren EPA (Eicosapentaensäure) und DHA (Docosapentaensäure) und Pektin und/oder Guar als wirksame Substanzen, sowie gegebenenfalls zusätzlichen Stoffen wie antioxidative Vitamine, Aminosäuren und Spurenelemente
FI114894B (fi) * 2002-05-02 2005-01-31 Omecol Finland Oy Elintarvikekoostumus
JP2004043337A (ja) * 2002-07-10 2004-02-12 Nisshin Oillio Ltd 血中中性脂肪濃度調整剤
TW200412942A (en) * 2002-08-06 2004-08-01 Abbott Lab Appetite control method
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
CA2515368A1 (en) * 2003-02-13 2004-08-26 Luciano Rossetti Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
CA2573854A1 (en) * 2004-07-13 2006-02-16 Rutgers, The State University Of New Jersey Omega fatty acid fortified food products and methods for preparing same
NZ553260A (en) * 2004-07-19 2010-12-24 Thia Medica As Composition comprising protein material and non-oxidizable fatty acid entities
US7456270B2 (en) 2004-09-01 2008-11-25 Abbott Laboratories Δ6-desaturase genes and uses thereof
WO2006041922A2 (en) * 2004-10-08 2006-04-20 Dara Biosciences, Inc. Agents and methods for administration to the central nervous system
EP1656839A1 (de) 2004-11-11 2006-05-17 N.V. Nutricia Nahrung, die eine Lipidmischung enthält
ATE401007T1 (de) * 2004-11-26 2008-08-15 Nutricia Nv Kleinkindernahrung mit proteasehemmer
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
WO2006088798A2 (en) * 2005-02-14 2006-08-24 Albert Einstein College Of Medicine Of Yeshiva University Modulation of hypothalamic atp-sensitive potassium channels
CA2537452C (en) * 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
BRPI0608610A2 (pt) * 2005-04-06 2010-01-19 Novartis Ag formulaÇço nutricional, regime dietÉtico, mÉtodos para melhorar nutricionalmente o controle da glicose e a aÇço da insulina, bem como usos
US9179702B2 (en) * 2005-07-13 2015-11-10 Abbott Laboratories Liquid nutritional compositions containing unsaturated fatty acids
US20070031538A1 (en) * 2005-07-13 2007-02-08 Gul Konuklar Liquid nutritional compositions containing n-3 polyunsaturated fatty acids
EP1964554A1 (de) * 2005-11-30 2008-09-03 Katry Inversiones, S.L. Lipid-gemisch und seine verwendung zur herstellung eines produkts zur enteralen oder oralen verabreichung
US20070218183A1 (en) * 2006-03-14 2007-09-20 Bunge Oils, Inc. Oil composition of conjugated linoleic acid
US20080089981A1 (en) * 2006-10-17 2008-04-17 N.V. Nutricia Ketogenic diet
GB2444896B (en) * 2006-12-18 2010-05-19 Nutraceuticals Ltd Compositions comprising polyunsaturated fatty acids
US8343541B2 (en) * 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002145A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002148A1 (en) * 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
AU2008269728B2 (en) 2007-06-26 2013-10-31 N.V. Nutricia Improving memory in subjects with mini-mental state examination of 24-26
US7943163B2 (en) 2007-08-22 2011-05-17 Response Scientific, Inc. Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes
US20090054513A1 (en) * 2007-08-22 2009-02-26 Response Scientific, Inc. Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
BRPI0822111B8 (pt) 2007-12-20 2021-05-25 Nutricia Nv composição líquida, e, uso de uma composição líquida
US20090197955A1 (en) * 2008-01-31 2009-08-06 Monsanto Company Methods of improving dha deposition and related function and/or development
BRPI0907367A8 (pt) * 2008-02-01 2021-03-30 Blackberry Ltd sistema e método para sincronização de sincronismo de enlace ascendente em conjunção com recepção descontínua
PL2334295T3 (pl) 2008-09-02 2017-12-29 Amarin Pharmaceuticals Ltd Kompozycja farmaceutyczna zawierająca kwas eikozapentaenowy i kwas nikotynowy oraz sposoby jej zastosowania
MX2011004379A (es) * 2008-10-29 2011-09-26 Preox Rs Gmbh Composicion nutricional que contiene acidos grasos omega-3 y mcts.
EP2351491B1 (de) 2008-11-06 2015-06-03 The Nisshin OilliO Group, Ltd. Ernährung aus konzentrierter flüssigkeit
US8060617B2 (en) * 2008-12-19 2011-11-15 Cisco Technology, Inc. Reserving network resources during scheduling of meeting event
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
EP3797591A1 (de) 2009-04-29 2021-03-31 Amarin Pharmaceuticals Ireland Limited Stabile pharmazeutische zusammensetzung und verfahren zur verwendung davon
AU2016219657B2 (en) * 2009-04-29 2018-02-01 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
BRPI1014405A2 (pt) 2009-04-29 2016-04-05 Amarin Corp Plc composições farmacêuticas compreendendo epa e um agente cardiovascular e métodos de seu uso
KR20120016677A (ko) 2009-06-15 2012-02-24 아마린 파마, 인크. 병용 스타틴 요법을 받는 대상체에서 ｌｄｌ－ｃ 수준을 상승시키지 않으면서 트리글리세리드를 저하시키기 위한 조성물 및 방법
SG10201405994UA (en) 2009-09-23 2014-10-30 Amarin Pharmaceuticals Ie Ltd Pharmaceutical Composition Comprising Omega-3 Fatty Acid And Hydroxy-derivative Of A Statin And Methods Of Using Same
US8372465B2 (en) 2010-02-17 2013-02-12 Bunge Oils, Inc. Oil compositions of stearidonic acid
NZ610471A (en) 2010-11-02 2014-12-24 Abbott Lab Stable concentrated liquid human milk fortifier
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
NZ712068A (en) 2010-11-29 2017-03-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
EP2775837A4 (de) 2011-11-07 2015-10-28 Amarin Pharmaceuticals Ie Ltd Verfahren zur behandlung von hypertriglyceridämie
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
PT2800563T (pt) * 2012-01-06 2018-11-07 Chrysalis Pharma Ag Composições enriquecidas com dpa de ácidos gordos omega-3 polinsaturados sob a forma de ácido livre
ES2891473T3 (es) 2012-01-06 2022-01-28 Amarin Pharmaceuticals Ie Ltd Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
KR20150028233A (ko) 2012-05-07 2015-03-13 옴테라 파마슈티칼스, 인크. 스타틴 및 오메가-３ 지방산의 조성물
EP2861227A4 (de) * 2012-06-17 2016-01-27 Matinas Biopharma Inc Omega-3 pentaensäurezusammensetzungen und verfahren zur verwendung
HUE053111T2 (hu) 2012-06-29 2021-06-28 Amarin Pharmaceuticals Ie Ltd Módszerek kardiovaszkuláris események veszélyének csökkentésére sztatin terápiával kezelt alanyban eikozapentaénsav-etilészter alkalmazásával
WO2014027022A1 (en) * 2012-08-14 2014-02-20 Nestec S.A. Dietetic compositions for the treatment of malnutrition, neurological diseases and metabolic diseases
WO2014027015A1 (en) * 2012-08-14 2014-02-20 Nestec S.A. Low ph process for the preparation of pasteurized compositions comprising high levels of fat, protein and carbohydrate
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
WO2015127320A2 (en) * 2014-02-20 2015-08-27 Iycus, Llc Single serve beverage compositions
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
EP3435787A1 (de) * 2016-03-30 2019-02-06 Nestec S.A. Nährstoffzusammensetzungen und deren verwendung
WO2018102914A1 (en) * 2016-12-06 2018-06-14 Transfert Plus, Société En Commandite Use of medium-chain triglycerides for the management of metabolic conditions
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
PT4056176T (pt) 2018-09-24 2024-05-27 Amarin Pharmaceuticals Ie Ltd Métodos de redução do risco de eventos cardiovasculares num indivíduo
JP2020150805A (ja) * 2019-03-18 2020-09-24 株式会社０ タンパク質高含有アイスクリーム
WO2022225896A1 (en) 2021-04-21 2022-10-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
US4871768A (en) * 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
US5288512A (en) * 1987-12-15 1994-02-22 The Procter & Gamble Company Reduced calorie fats made from triglycerides containing medium and long chain fatty acids
US5000975A (en) * 1988-12-29 1991-03-19 American Home Products Corporation Randomized palm oil fat composition for infant formulas
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
US5223285A (en) 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
DE4304394A1 (en) 1993-02-13 1993-09-02 Fresenius Ag Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response
DE4417851C1 (de) 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung
DE19503993A1 (de) 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen

Also Published As

Publication number Publication date
ES2179156T3 (es) 2003-01-16
US5886037A (en) 1999-03-23
PT843972E (pt) 2002-12-31
NO975299L (no) 1998-05-22
EP0843972A1 (de) 1998-05-27
EP0843972B1 (de) 2002-07-31
DK0843972T3 (da) 2002-12-02
DE69622722T2 (de) 2003-02-27
DE69622722D1 (de) 2002-09-05
NO975299D0 (no) 1997-11-19
NO320263B1 (no) 2005-11-14

Similar Documents

Publication Publication Date Title
ATE221324T1 (de) Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms
Vidgren et al. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men
ATE331510T1 (de) Verwendung von polyungesättigten fettsäuren zur primären vorbeugung von kardiovaskulären anfällen
Finley et al. The chemistry, processing, and health benefits of highly unsaturated fatty acids: an overview
ATE265207T1 (de) Verwendung von mehrfach ungesättigten fettsäuren zur vorbeugung von nekrotizierender enterokolitis
IS5017A (is) Lyfjasamsetning sem inniheldur eikósapentaensýru og/eða stearidónsýru
DK1121115T3 (da) PUFA-tilskud
KR940018091A (ko) 불포화 지방산을 포함하는 처방
SE8405308D0 (sv) Farmaceutisk komposition och forfarande for framstellning av densamma
DK0623019T3 (da) Medikamenter på basis af docosahexaensyre som midler mod blodpladeaggregation og mod cerebral mangel på essentielle fedtsyr
AU2441400A (en) Stabilized lipidic composition, method for the preparation thereof and nutritional product containing the same
DK0754001T3 (da) Næringsmiddelprodukt til behandling af colitis ulcerosa og anvendelse deraf
NZ304924A (en) hybridised triglycerides
RU2135555C1 (ru) Пищевой антиоксидант
Spurvey Production of structured lipids via enzymatic interesterification of gamma-linolenic acid (GLA) and marine oils
MY129218A (en) Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification